Zeiss launch new solution updates

Article

Carl Zeiss Meditec presented its expanded offering of ophthalmic solutions at this year's WOC 2010 in Berlin.

Carl Zeiss Meditec presented its expanded offering of ophthalmic solutions at this year's WOC 2010 in Berlin.

Amongst its offerings was the IOLMaster 500 which it claims is the fastest way of calculating the right IOL for every patient. It is part of the ZEISS Toric Solution and, via the FORUM platform, is an integral component of the ZEISS Ophthalmic Data Management Solution, a platform for the management of patient, diagnostic and OR data, for a paperless workflow in the doctor's practice and operating room.

The bitoric MICS intraocular lenses are a new standard range (lenses to +4.0 D cyl and 16-24 D sph) The lenses can be calculated quickly and simply using the Z CALC online calculator.

The AT LISA toric 909MV belongs to the ZEISS IOL family featuring violet filters. Besides UV protection these IOLS offer protection from the potentially more dangerous violet light spectrum. At the same time they transmit blue light, which plays an important role in regulation of the circadian rhythm, without impairing visual quality.

In the OVD Portfolio are the visco-elastic substances used for cataract treatment to enhance visibility of the operation area during the procedure and protect the corneal endothelium.

OPMI Lumera 700 is a surgical microscope which combines basic configuration with extensive options for surgery in the anterior and posterior ocular segments. The new RESIGHT 700 fundus viewing system and innovative Stereo Coaxial Illumination (SCI) illumination technology, allows the doctor to see the patient's eye with detail and brilliance.

Dr Ludwin Monz, President and CEO of Carl Zeiss Meditec AG said: “We have developed these innovations in close dialogue with our customers and we remain on course to further success as a solution provider for ophthalmology and therefore make a contribution to the more effective and efficient treatment of diseases.”

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.